Aminoacylase 1 deficiency

From WikiMD's WELLNESSPEDIA


Aminoacylase 1 deficiency
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Developmental delay, Intellectual disability, Seizures
Complications N/A
Onset Infancy
Duration Lifelong
Types N/A
Causes Genetic mutation in the ACY1 gene
Risks N/A
Diagnosis Genetic testing
Differential diagnosis N/A
Prevention N/A
Treatment Supportive care
Medication N/A
Prognosis N/A
Frequency Rare
Deaths N/A


Aminoacylase 1 deficiency is a rare metabolic disorder caused by mutations in the ACY1 gene. This condition is characterized by a range of symptoms including developmental delay, intellectual disability, and seizures.

Genetics[edit]

Aminoacylase 1 deficiency is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected. The ACY1 gene provides instructions for making an enzyme called aminoacylase 1, which is involved in the breakdown of N-acetylated amino acids.

Symptoms[edit]

The symptoms of aminoacylase 1 deficiency can vary but often include:

Diagnosis[edit]

Diagnosis of aminoacylase 1 deficiency is typically confirmed through genetic testing that identifies mutations in the ACY1 gene. Additional tests may include metabolic screening and neuroimaging to assess the extent of neurological involvement.

Treatment[edit]

There is currently no cure for aminoacylase 1 deficiency. Treatment is focused on managing symptoms and may include:

Prognosis[edit]

The prognosis for individuals with aminoacylase 1 deficiency varies depending on the severity of symptoms. Early intervention and supportive therapies can improve quality of life.

Research[edit]

Ongoing research is focused on understanding the molecular mechanisms of aminoacylase 1 deficiency and developing potential therapies.

See also[edit]

References[edit]


External links[edit]